![]() | ![]() |
Cipla and Takeda to Commercialize Vonoprazan in India
Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.
Patent License Agreement | 27/06/2024 | By Aishwarya | 326
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy